Download FREE Practo app
Get ₹200 HealthCash
Adenocarcinoma left lung
Patient data suggests that non-small cell lung cancer with mutations in the tyrosine kinase domain ( Exon 18- 21) of the EGFR gene may respond to anti-EGFR therapies directed against the tyrosine kinase domain.
Answers (2)
Like the answers? Consult privately with the doctor of your choice
Yes. That's true. Targeted therapy in the form of anti EGFR drugs have proven effective in lung cancer patients with EGFR gene mutations.
Answered
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
YES
NO
Didn't find the answer you are looking for?
Talk to experienced oncologist online and get your health questions answered in just 5 minutes.
+118
That is right...
Next Steps
you should consider treatment.. lot of options are available
Answered
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
YES
NO
Articles you may like
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
The question asked on this page is a free question. You can ask a free health question by downloading the Practo app.
Articles you may like
Tell us what's troubling you
Tell us what's troubling you
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.